Akademska digitalna zbirka SLovenije - logo

Search results

Basic search    Expert search   

Currently you are NOT authorised to access e-resources SI consortium. For full access, REGISTER.

1 2 3 4 5
hits: 75
1.
Full text
Available for: CMK, UL

PDF
2.
  • Antibody Persistence throug... Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
    Doria-Rose, Nicole; Suthar, Mehul S; Makowski, Mat ... New England journal of medicine/˜The œNew England journal of medicine, 06/2021, Volume: 384, Issue: 23
    Journal Article
    Peer reviewed
    Open access

    A total of 33 participants who received both doses of the Moderna mRNA-1273 vaccine against SARS-CoV-2 had blood drawn over a period of 6 months after vaccination. SARS-CoV-2 neutralizing activity ...
Full text
Available for: CMK, UL

PDF
3.
  • What is the role of remdesi... What is the role of remdesivir in patients with COVID-19?
    Beigel, John H. Current opinion in critical care, 10/2021, Volume: 27, Issue: 5
    Journal Article
    Open access

    Purpose of review COVID-19 represents an unprecedented public health crisis caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The antiviral remdesivir is one component of ...
Full text
Available for: CMK

PDF
4.
  • Advances in respiratory vir... Advances in respiratory virus therapeutics – A meeting report from the 6th isirv Antiviral Group conference
    Beigel, John H.; Nam, Hannah H.; Adams, Peter L. ... Antiviral research, 07/2019, Volume: 167
    Journal Article
    Peer reviewed
    Open access

    The International Society for Influenza and other Respiratory Virus Diseases held its 6th Antiviral Group (isirv-AVG) conference in Rockville, Maryland, November 13–15, 2018. The three-day program ...
Full text
Available for: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UILJ, UL, UM, UPCLJ, UPUK, ZAGLJ, ZRSKP

PDF
5.
  • Polyclonal and monoclonal a... Polyclonal and monoclonal antibodies for the treatment of influenza
    Beigel, John H Current opinion in infectious diseases, 2018-December, 2018-12-00, 20181201, Volume: 31, Issue: 6
    Journal Article
    Peer reviewed

    PURPOSE OF REVIEWThis review summarizes past and ongoing efforts for using polyclonal and monoclonal antibodies for the treatment of influenza, and is focused on products that have entered clinical ...
Full text
Available for: CMK
6.
  • Erythema and Induration aft... Erythema and Induration after Mpox (JYNNEOS) Vaccination Revisited
    Frey, Sharon E.; Goll, Johannes B.; Beigel, John H. New England journal of medicine/˜The œNew England journal of medicine, 04/2023, Volume: 388, Issue: 15
    Journal Article
    Peer reviewed
    Open access

    In a trial of mpox vaccine, intradermal administration led to more erythema and induration than the subcutaneous route but resulted in a similar level of immune response with 20% of the dose.
Full text
Available for: CMK, UL
7.
  • Durability of Responses aft... Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
    Widge, Alicia T; Rouphael, Nadine G; Jackson, Lisa A ... New England journal of medicine/˜The œNew England journal of medicine, 01/2021, Volume: 384, Issue: 1
    Journal Article
    Peer reviewed
    Open access

    Thirty-four adults received two 100-μg injections of Moderna’s mRNA SARS-CoV-2 vaccine, and serum anti–spike protein and neutralizing antibody titers were measured at day 119 — 90 days after the ...
Full text
Available for: CMK, UL

PDF
8.
  • The role of adjuvant immuno... The role of adjuvant immunomodulatory agents for treatment of severe influenza
    Hui, David S.; Lee, Nelson; Chan, Paul K. ... Antiviral research, 02/2018, Volume: 150
    Journal Article
    Peer reviewed
    Open access

    A severe inflammatory immune response with hypercytokinemia occurs in patients hospitalized with severe influenza, such as avian influenza A(H5N1), A(H7N9), and seasonal A(H1N1)pdm09 virus ...
Full text
Available for: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPCLJ, UPUK, ZRSKP

PDF
9.
  • Human antibody repertoire a... Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies
    Khurana, Surender; Fuentes, Sandra; Coyle, Elizabeth M ... Nature medicine, 12/2016, Volume: 22, Issue: 12
    Journal Article
    Peer reviewed
    Open access

    Development of an effective vaccine against Ebola virus is of high priority. However, knowledge about potential correlates of protection and the durability of immune response after vaccination is ...
Full text
Available for: IJS, NUK, SBMB, UL, UM, UPUK

PDF
10.
  • SARS-CoV-2 Omicron Variant ... SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
    Pajon, Rolando; Doria-Rose, Nicole A; Shen, Xiaoying ... New England journal of medicine/˜The œNew England journal of medicine, 03/2022, Volume: 386, Issue: 11
    Journal Article
    Peer reviewed
    Open access

    Neutralization of the omicron variant was assessed in serum samples obtained from persons who had received an mRNA-1273 booster. After the standard two-dose vaccine regimen, these titers were ...
Full text
Available for: CMK, UL

PDF
1 2 3 4 5
hits: 75

Load filters